Braida et al., 2014b |
Nicotine |
Improved performance |
T-maze |
Braida et al., 2014b |
Nicotine |
Increased discrimination score |
Object recognition test |
Eddins et al., 2009; Levin & Chen, 2004; Levin et al., 2006
|
Nicotine |
Increased accuracy |
Spatial discrimination test |
Kedikian et al., 2013 |
Nicotine |
Enhanced place preference |
Conditioned place preference (for drug) |
Braida et al., 2014b |
Cytisine (and cytisine-derived partial agonists) |
Improved performance |
T-maze |
Darland & Dowling 2001; Darland et al., 2012
|
Cocaine |
Enhanced place preference |
Conditioned place preference (for drug) |
Webb et al., 2009; Ninkovic & Bally-Cuif, 2006
|
Amphetamine |
Enhanced place preference |
Conditioned place preference (for drug) |
Chacon & Luchiari, 2014; Mathur et al., 2011
|
Ethanol |
Enhanced place preference |
Conditioned place preference (for drug) |
Chacon & Luchiari, 2014 |
Ethanol |
Memory impairment |
Associative learning |
Pittman & Lott, 2014 |
Ethanol |
Impaired performance |
Vertical column plus-maze |
Lau et al., 2006 |
Morphine |
Enhanced place preference |
Conditioned Place Preference (for drug) |
Kim et al., 2010; Richetti et al., 2011
|
Scopolamine |
Memory impairment |
Passive avoidance |
Cognato et al., 2012 |
Scopolamine |
Reduced exploration (novel arm) |
Y-maze |
Sison & Gerlai, 2011 |
MK-801 |
Learning impairment |
Associative learning |
Swain et al., 2004 |
MK-801 |
Decreased place preference |
Conditioned Place Preference (for food) |
Cognato et al., 2012 |
MK-801 |
Memory impairment |
Y-maze |
Blank et al., 2009; Ng et al., 2012; Seibt et al., 2011
|
MK-801 |
Learning/memory impairment |
Avoidance learning (various) |
Cofiel & Mattiolo, 2009 |
L-histidine |
Facilitated learning |
Associative learning |
Pittman & Lott, 2014 |
Fluoxetine |
Impaired performance |
Plus maze |
Grossman et al., 2011 |
Piracetam |
Improved performance |
Plus maze |
Ruhl et al., 2014 |
THC |
Memory impairment |
Spatial memory test |
Grossman et al., 2010 |
LSD |
Improved performance |
T-maze |
Braida et al., 2007 |
Salvinorin A |
Enhanced place preference |
Conditioned place preference (for drug) |